GE buys interest in DNA

Share this article:

General Electric has scooped up Thermo Fischer Scientific's DNA purifying and cell-line growing technology for just over $1 billion, Bloomberg reports.

The deal helps both companies pursue their respective business objectives. Bloomberg notes that the deal means GE will now be able to promote technologies that aid discovery and manufacturing of medicines and diagnostics, somewhat counterbalancing its exit from consumer finance.

At the same time, Bloomberg notes, the divestiture could help Thermo Fischer get EU approval to acquire Life Technologies Corp. for $13.6 billion. This deal would put Life's genetic testing and mapping equipment under Thermo's roof.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Business Briefs

Novartis said to be stepping out of HCV

Novartis is said to have relinquished rights to an investigational hep. C treatment, signaling its exit from the therapeutic space, according to a former partner's announcement.

Monday Moves: September 15

Hires and promotions for manufacturers, regulatory and agencies

Kantar acquires Evidências, expands Brazilian presence

The company's acquisition signals the growing importance of understanding the Brazilian healthcare market and evidence-based healthcare management services.